Evidence map›Paper›PMID 41298612›Full record

ArticleScientific reports2025

AUPA: weakly supervised approach for streamlining breast cancer diagnostic workflow by WSI histological type classification for efficient IHC triage.

M J Garcia-Gonzalez, Jhon Comba Miranda, Jose Luis Rey Sanjurjo, Laura Valeria Perez-Herrera, Blanca Cimadevila Alvarez, Xabier Echeberria-Barrio, Francesco Zola, Ivan Macia Oliver, Valery Naranjo Ornedo, Karen Lopez-Linares Roman

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

M J Garcia-GonzalezVicomtech Foundation, Basque Research and Technology Alliance (BRTA), Donostia-San Sebastián, Spain. mjgarcia@vicomtech.org.
Jhon Comba MirandaeHealth Group, Bioengineering Area, Biogipuzkoa Health Research Institute, Donostia-San Sebastián, Spain.
Jose Luis Rey SanjurjoPathology Department, Servicio Gallego de Salud (SERGAS), Galicia, Spain.
Laura Valeria Perez-HerreraVicomtech Foundation, Basque Research and Technology Alliance (BRTA), Donostia-San Sebastián, Spain.
Blanca Cimadevila AlvarezPathology Department, Servicio Gallego de Salud (SERGAS), Galicia, Spain.
Xabier Echeberria-BarrioVicomtech Foundation, Basque Research and Technology Alliance (BRTA), Donostia-San Sebastián, Spain.
Francesco ZolaVicomtech Foundation, Basque Research and Technology Alliance (BRTA), Donostia-San Sebastián, Spain.
Ivan Macia OliverVicomtech Foundation, Basque Research and Technology Alliance (BRTA), Donostia-San Sebastián, Spain.
Valery Naranjo OrnedoInstituto Universitario de Investigación en tecnología centrada en el ser humano (Human-Tech), Universitat Politècnica de València (UPV), Valencia, Spain.
Karen Lopez-Linares RomanVicomtech Foundation, Basque Research and Technology Alliance (BRTA), Donostia-San Sebastián, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In routine breast cancer diagnostics, pathologists often review each case twice-first to determine the need for immunohistochemical (IHC) stains, and a second time to issue the final diagnosis-creating significant workload and delays. We present an artificial intelligence-based system designed to streamline this process by distinguishing invasive carcinoma from fibroadenoma and in situ lesions in Whole Slide Images of H&E-stained breast biopsies, enabling automatic IHC stain requests for these lesions, while abstaining on non-target or low-confidence cases. The system leverages a weakly supervised method, trained directly on final diagnostic labels without the need for manual annotations. It achieves over 91% sensitivity and specificity across histological types in internal validation and shows strong generalizability in two external pilot studies. In a real-world setting, the system could determine if IHC stains should be ordered (sensitivity and specificity > 96%) and which stains (sensitivity and specificity > 81%). Compared to both expert pathologists and state-of-the-art models, our model performs competitively. Designed for real-world deployment, it is fully integrated into the Digital Imaging and Communications in Medicine (DICOM) standard. In validation data, it could have saved up to 43 h of pathologists' time. Our model represents a scalable solution for more efficient diagnostic BC workflows.

Indexed as

Breast NeoplasmsImmunohistochemistryArtificial IntelligenceFemaleHumansSensitivity and SpecificityTriageWorkflow

Identifiers

PMID41298612
PMCPMC12657984

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.